MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$116.62-1.88%
Price as of Jul 20, 2026
MIRM valuation
Mirum Pharmaceuticals, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 4314.63x
- P/E 2028E
- 63.46x
- P/S forward
- 10.02x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 29.33x
- Price / sales
- 12.49x
- Price / cash flow
- -41.59x
Enterprise value
- Enterprise value
- $7.0B
- EV / sales
- 12.38x
- EV / EBITDA
- -9.26x
- EV / EBIT
- -100.54x
- Market cap
- $7.1B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.